Deutsche Bank Ag\ Amgen Inc Put Options Transaction History

Deutsche Bank Ag\

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $15,125 - $20,061	-83 Reduced 58.45%	59 $12,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $3,405 - $4,377	-18 Reduced 11.25%	142 $34,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $13,406 - $16,063	77 Added 92.77%	160 $30,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $438,420 - $513,928	-2,630 Reduced 96.94%	83 $15,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $445,844 - $502,564	2,465 Added 993.95%	2,713 $515,000
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $178 - $208	-1 Reduced 0.4%	248 $48,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $18,529 - $20,889	100 Added 67.11%	249 $51,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $14,280 - $16,039	86 Added 136.51%	149 $27,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $45,746 - $53,460	-270 Reduced 81.08%	63 $10,000
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $25,318 - $28,288	-150 Reduced 31.06%	333 $57,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $80,801 - $92,253	483	483 $89,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.